HomeOpen Access NewsHealthcare Research

Healthcare Research

AI breakthrough identifies active brain neurons

A neuroscience mystery has been solved by using artificial intelligence (AI) to identify the electrical signatures of different types of brain neurons for the first time.

New study will investigate long-term effects of COVID-19 lung damage

A new national study, funded by UK Research and Innovation (UKRI), will investigate the long-term effects of COVID-19 lung damage.

NHS contract given to Health Secretary Matt Hancock’s family company

According to HSJ, Health Secretary Matt Hancock's family-owned company were awarded an NHS contract for services - but the Secretary failed to declare any connection to Topwood Ltd.

One in four HIV patients experience intimate partner violence

According to the CDC, one in four HIV patients in the United States experience intimate partner violence - which could be anything between physical assault to stalking.

Scientists create blood test for depression and bipolar disorder

Indiana University of Medicine researchers spent four years developing a blood test to identify depression and bipolar disorder - they say this work will bring psychiatry from "the 19th century into the 21st".

Center for Disease Control says surfaces “low-risk” for COVID transmission

New CDC guidelines suggest that surfaces are a "low-risk" for COVID transmission - cleaning surfaces with detergent or soap once a day should be enough to reduce possible virus levels.

Healthy under-30s should take alternative vaccine to AstraZeneca

The UK's medical authorities cleared continued use of AstraZeneca, but say that 18-29 year olds should take an alternative vaccine to AstraZeneca if possible.

Moderna COVID vaccine rollout begins in UK

The Moderna COVID vaccine will initially be given to patients in Wales - which brings the UK up to three approved vaccines.

HealthTracker™ for patients, clinician & researchers

Professor Paramala Santosh, CEO of HealthTracker Ltd, co-developed the HealthTrackerTM platform – developed by clinicians, assisted by patients for patients, clinicians & researchers, more of which we learn about here.

Scientists find Pfizer vaccine is 100% effective in young adolescents

The company aim to start vaccinating children by September 2021, as clinical trials reveal that Pfizer is 100% effective in those aged 12 to 15.

Scientists find Black pupils have highest rate of autism in UK

In an investigation of over seven million pupils, researchers found that Black pupils have the highest rate of autism in the UK - they further noticed that there is "little research" on the existence of autism in ethnic minorities.

Vaccine shortage in UK means under-50s to wait longer for first dose

The NHS released new information explaining that there would be a vaccine shortage in the UK from 29 March, meaning under-50s will wait longer for their first jab as second doses are given to the most vulnerable cohorts.

Llamas create COVID-19 antibodies that humans can inhale as a vaccine

Scientists at the University of Pittsburgh are creating COVID-19 antibodies in llamas, to understand how humans could engineer better immune responses.

How will data from remote diagnosis change healthcare?

José Bastos, Director at knok, explores how data from remote diagnosis will alter healthcare and discusses how knok will play its part in this digital transformation journey.

Are swollen lymph nodes normal after getting the COVID vaccine?

According to radiologists at Massachusetts General Hospital (MGH), swollen lymph nodes after COVID vaccination are a "normal reaction that typically goes away with time".

What are the priority groups for phase two of UK vaccinations?

The Government unveiled the confirmed priority groups for phase two of UK vaccinations - the Joint Committee on Vaccination and Immunisation (JCVI) is choosing age as the deciding factor.

The Pfizer vaccine is stopping 92% of severe COVID cases in Israel

Israel is currently leading the world in COVID vaccination, with real-world data to suggest that the Pfizer vaccine is working to stop 92% of severe COVID cases.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders